CPAP-treated patients' behaviours during the COVID-19 crisis

Obstructive sleep apnoea (OSA) is one of the most prevalent chronic diseases affecting nearly one billion people worldwide [1]. Continuous positive airway pressure (CPAP) is the first-line therapy for obstructive sleep apnoea (OSA) [1] being currently used by over one million people throughout France. A focus on the OSA population during the COVID-19 outbreak is of particular interest for two main reasons: (i) OSA is a multi-morbid disease with up to 70% of patients being obese [3] and exhibiting a high prevalence of cardio-metabolic comorbidities. Footnotes This manuscript has recently been accepted for publication in the ERJ Open Research . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article. Conflict of interest: Dr. Pepin reports grants from French National Research Agency, grants from Grenoble-Alpes University Foundation, grants from MIAI@Grenoble Alpes, during the conduct of the study. Conflict of interest: Dr. Sauvaget has nothing to disclose. Conflict of interest: Dr. Borel has nothing to disclose. Conflict of interest: Dr. Rolland has nothing to disclose. Conflict of interest: Dr. Sapene has nothing to disclose. Conflict of interest: Dr. Pepin reports grants from French National Research Agency, grants from Grenoble-Alpes University Foundation, grants from MIAI@Grenoble Alpes, during the conduct of the study. Conflict of interest: Dr. Pepin reports grants from French National Research Agency, grants from Grenoble-Alpes University Foundation, grants from MIAI@Grenoble Alpes, during the conduct of the study. Conflict of interest: Dr. Pepin reports grants from French National Research Agency, grants from Grenoble-Alpes University Foundation, grants from MIAI@Grenoble Alpes, during the conduct of the study.